
Li Tao, PhD, discusses early US uptake of twice-yearly lenacapavir, faster prescription-to-injection timelines, and how ACA coverage milestones tracked with zero cost sharing and HIV diagnoses.
Here are the top takeaways from the European Congress of Clinical Microbiology and Infectious Disease 2019 meeting.
Read more about these stories:






